Back
Humana Inc (HUM)
Health CareHUM · NEW YORK STOCK EXCHANGE, INC. · USD
New to investing? How to read this page →$392.86
−0.98%Price · 1 year
Loading live analysis…
Loading analysis…
Intrinsic Investor is for education and research only — not financial advice.
Key metrics
EPS
$9.83
ROE
6.3%
Gross margin
14.0%
Debt/Equity
0.77x
Revenue growth
23.5%
Humana Inc — company intelligence
Earnings surprises
Q1 2026$10.31 vs $10.29 est+0.2%
Q4 2025$-3.96 vs $-4.05 est+2.1%
Q3 2025$3.24 vs $2.85 est+13.8%
Q2 2025$6.27 vs $5.98 est+4.9%
Analyst consensus · 33 analysts
11 Buy20 Hold2 Sell
Updated Jul 6, 2026
Insider activity · 90 days
10 buys0 sellsnet +111,780 shares
HILZINGER KURT JBuy 233 · Jun 30, 2026
Field Robert StuartBuy 852 · May 1, 2026
Martin AaronBuy 8,206 · May 1, 2026
Recent SEC filings
4 — Insider transaction reportJul 2, 2026
8-K — Material event reportJun 1, 2026
8-K — Material event reportMay 19, 2026
Latest news
PCRX's Exparel Wins Separate Reimbursement From UnitedHealthcare — Yahoo · 1w ago
UnitedHealth to Top Second-Quarter Earnings Views on Favorable Utilization Trends, Morgan Stanley Says — Yahoo · 1w ago
The Humana Foundation Deepens Investment in Emotional Health, Announcing Over $12 Million in New Grants — Yahoo · 1w ago
AI Valuation Narrative
Generates a short bull / bear / catalyst summary from the analytics we already computed. No target prices. Research tool, not investment advice.
Explore more
Peers & similar stocks
Quick links to related tickers for research.
About Humana Inc
Weekly undervalued picks (like HUM)
Get 3 new value ideas and the fair-value math behind them every week. One email, unsubscribe anytime.
Free. No spam. We only email once per week.
Data is provided "as-is" and may be delayed or incomplete. Intrinsic Investor is for education only and is not investment advice.